Eur Rev Med Pharmacol Sci 2017; 21 (2 Suppl): 30-35

Myo-inositol as a male fertility molecule: speed them up!

R.A. Condorelli, S. La Vignera, L.M. Mongioì, S.G. Vitale, A.S. Laganà, L. Cimino, A.E. Calogero

Unit of Andrology and Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. sandrolavignera@unict.it

Myo-inositol (MYO) usually represents a therapeutic option for female infertility associated with insulin resistance. Recently, several evidences are accumulating about the potential use of MYO for the treatment of male infertility. This article summarizes the rationale for MYO in the treatment of male infertility. In particular, it illustrates the potential antioxidant and prokinetic role of MYO, and its importance for the modulation of hormonal regulation. In the final part of the manuscript has been added a proposal for a clinical algorithm reserved for patients with asthenozoospermia, where probably MYO could exert specific pharmacological effects.

Published on: 2017/07/06


Free PDF Download

To cite this article

R.A. Condorelli, S. La Vignera, L.M. Mongioì, S.G. Vitale, A.S. Laganà, L. Cimino, A.E. Calogero
Myo-inositol as a male fertility molecule: speed them up!

Eur Rev Med Pharmacol Sci
Year: 2017
Vol. 21 - N. 2 Suppl
Pages: 30-35

Keywords Related articles:

  1. The Combined therapy with myo-inositol and D-Chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone
  2. Contribution of electron microscopy to study in vitro inositol effects on human spermatozoa
  3. Cryptorchidism and its long-term complications
  4. Inositol: history of an effective therapy for Polycystic Ovary Syndrome
  5. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial